NESS ZIONA, Israel, October 17,
2017 /PRNewswire/ --
NRGene, the worldwide leader in genomic assembly and analysis,
has demonstrated its ability to discover, analyze, and track
abnormalities within the human genome, across multiple
subjects.
As part of a proof of concept, NRGene's GenoMAGICTM
provided a complete analysis of a family's genomic profile based on
low (8X) coverage whole genome sequencing information. The system
detected the heritable haplotypes and the causal rare mutation
underlying the family's colon cancer. This finding demonstrates
GenoMAGIC's ability to perform accurate whole genome analysis from
low coverage data and quickly detect familial disease genes.
As part of a collaborative project with Dr. Hanlee P. Ji, Associate Professor of Medicine
(Oncology) at Stanford University,
NRGene's analytic technology was found to accurately identify
pathogenic mutations from a family with a hereditary cancer
syndrome.
With GenoMAGIC TM, NRGene delivers a complete
solution for population genomics and large-scale, next-generation
human genomics research. It analyzes complex genomic data and
translates it into accessible, straightforward information. The
cloud-based platform is fully scalable as data from multiple
sources can be quickly and easily integrated. A dedicated GUI
delivers complete visualization of data queries.
GenoMAGICTM is at the forefront of bioinformatics
research and analysis, allowing the creation and constant updating
of a population-scale haplotypes database. The system delivers
Genome Wide Association Studies (GWAS) and biomarker discovery - as
with the colon cancer mutation demonstration.
"NRGene technology has been proven to find the genomic diversity
among crops like wheat, whose genome is five times the size of the
human genome," said NRGene CEO Gil
Ronen. "Finding the colon cancer causal mutation so
efficiently demonstrates how our technology can support high
throughput discovery of other abnormalities in the human genome,
accelerating genetic-based disease research and delivering
information toward finding cures."
Dr. Ji will be presenting his results of the collaboration
with NRGene on October 18 2017, at
11 a.m. ET at the American Society of
Human Genetics Conference in Orlando.
About NRGene
NRGene is a genomic big data company developing cutting-edge
software and algorithms to reveal the complexity and diversity of
humans, plants, and animals for supporting the most advanced and
sophisticated breeding programs. NRGene tools have already been
employed by some of the leading seed companies worldwide as well as
the most influential research teams in academia.
http://www.nrgene.com.
NRGene Contact
Amy Kenigsberg
K2 Global Communications
amy@k2-gc.com
+1-913-440-4072 (+7 ET)
+972-9-794-1681 (+2 GMT)
SOURCE NRGene